Genetic analysis identified a homozygous c.355del p.(His119ThrfsTer5) pathogenic variant in HPS1, confirming HPS-1.<h4>Interventions and outcomes</h4>Abatacept was discontinued and rituximab initiated for RA management. The gene discussed is HPS1; the disease is rheumatoid arthritis.